VCP Scanner
Stock Screener
Filter stocks with fundamental & technical criteria
Market Themes
Curated industry baskets & thematic leaders
Earnings Hub
Calendar, EPS surprise stats & earnings transcripts
Market News
Real-time market intelligence & AI overviews
Insider Buying
SEC Form 4 corporate insider purchases
MinerviniVCP SetupsTrend Template
O'NeilCup with HandleFlat BaseDouble BottomCANSLIM Leaders
QullamaggieHigh Tight FlagsFlag BreakoutsEpisodic PivotsMomentum Leaders
KellWedge PopEMA Crossback
LivermorePivotal Points
PatternsFalling Wedge & ChannelBase Breakouts
View All Playbooks...
BreakoutsScanner
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Index & ETFs
SPY vs QQQVTI vs VOOSPY vs IWM
Compare Any Stocks...
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
VisualizeInteractive multi-year financial charts
Watchlist
BreakoutsScanner
WatchlistPricing
Ctrl K
Pricing
PRE
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Analyze deeply. Research with clarity.

Data updated daily

Product

  • Screener
  • Scanner
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • Pricing
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly market insights — free

© 2026 VCP Scanner
AboutPrivacyTermsRefund Policy
Not financial advice. Do your own research.
ScreenerBreakoutsScannerWatchlist
PREPrenetics Global Limited
$15.94$271M
Overview & Tools
OverviewChart Terminal ↗Visualize
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice History
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Discovery & Screens
Live BreakoutsStock ScreenerOwnership
PRE logo

Prenetics Global Limited

PRE
NASDAQ · Packaged Foods
$15.94
At close - Nov 6, 4:00 PM EST - USD
Market Cap$271M
P/E-4.1x
52W High$27.24
Volume100.71K
OverviewTerminalAnalysisFinancialsValuationEarningsBreakoutsOwnership
VCP Research Verdict2026Q2

Rapid Scale-Up Clouded by Deep Cash Burn

Prenetics Global's revenue scaled from $6.4M in 2024Q1 to $46.5M in 2026Q2, with gross margins recovering to 65.0% — broadly in line with diagnostics peers — yet operating losses deepened to -$21.9M as SG&A reached $51.4M per quarter, suggesting operating leverage remains unproven.

GrowthExpanding
ProfitabilityStrained
ValuationReview
TechnicalsWeak
Explore valuation models
MARKET ACTION

PRE price & volume

Price trend, volume and key moving averages

Launch Terminal
Loading chart...
Decision Checklist4 Core Signals

What matters now

The signals most likely to change the investment case.

01

Earnings momentum

6/12 Beats

EPS beat 6 of last 12 quarters

02

Valuation risk

-113% Peers

P/E is 113% below peer median

03

Market leadership

RS 34 · Lag

Laggard (Underperforming 66% of market)

04

Weak Trend

Below 200DMA

Price < 200DMA

Next CatalystConfirmed earnings · Nov 18

Market performance

Price History →

Trailing total returns as of 11/8/2026, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC).

YTD Return
PRE+1.01%
S&P 500 (^GSPC)+7.63%
1-Year Return
PRE+29.07%
S&P 500 (^GSPC)+9.69%
3-Year Return
PRE+230.71%
S&P 500 (^GSPC)+66.40%
5-Year Return
PRE-86.18%
S&P 500 (^GSPC)+55.72%

Growth & profitability

Annual revenue & EPS trend
Revenue FY25
$92M+201.7% YoY
Net income FY25
-$38M+18.6% YoY
Free cash flow FY25
-$22M+26.5% YoY
Operating margin FY25
-41.3%+116.0 pts YoY
ROIC (FY25)-21.2%
Avg ROIC 5Y-46.5%
ROE (TTM)-49.2%
Piotroski Score6 / 9
Financial Statements →
03

Monitor what changed

Recent results and news deserve attention only when they alter the forward view.

OPERATING RESULTS

Recent Earnings

Earnings History
EPS Beat Rate6/12 (50%)
Revenue Beat Rate3/12 (25%)
QuarterEPS (Act vs Est)Revenue (Act vs Est)
Q3 2026Latest
Aug 18, 2026
-$0.53+36.9%
vs -$0.84
$46M-6.7%
vs $50M
Q3 2026
Jun 10, 2026
-$1.36-177.6%
vs -$0.49
$36M-0.1%
vs $36M
Q1 2026
Feb 18, 2026
-$1.75-326.8%
vs -$0.41
$37M+9.5%
vs $33M
Q4 2025
Nov 10, 2025
-$0.41+25.5%
vs -$0.55
$24M-9.4%
vs $26M
Historical baseline: 12 quarters analyzedGAAP / Adjusted
MARKET COVERAGE

Latest News

4 Stories
PRNewsWire·3d ago
Care Bears And Prenetics' IM8 Announce Global Partnership

IM8 family wellness brand to launch gummy multivitamins for kids and adults in 2027, marking Care Bears' 45th anniversary NEW YORK, Nov. 5, 2026 /PRNewswire/ -- Care Bears, part of Authentic Brands Group ("Authentic") and Prenetics Global Limited (Nasdaq: PRE) ("Prenetics"), parent of IM8, the wellness brand co-founded by David Beckham, today announced an exclusive 10-year worldwide partnership to launch Care Bears by IM8, a family health and wellness brand. The partnership joins Care Bears' multigenerational appeal and global reach with IM8's science-first formulations, quality standards and digital commerce capabilities.

GlobeNewsWire·3d ago
Prenetics' IM8 and Authentic Brands Group Announce 10-Year Exclusive Global Partnership to Create Care Bears by IM8; Authentic to Become Strategic Shareholder in Prenetics

Care Bears by IM8 to launch, with great-tasting, science-backed gummy multivitamins for kids and adults in 1H 2027 Enters a global gummy supplements market projected to nearly double to ~US$47.8 billion by 2030 IM8 to serve as exclusive operating partner, with Prenetics recording all Care Bears by IM8 revenue To get early access, visit www.carebearsbyIM8.com NEW YORK, Nov. 05, 2026 (GLOBE NEWSWIRE) -- Prenetics Global Limited (NASDAQ: PRE) (“Prenetics” or the “Company”), a leading consumer health company and parent of the AI-native direct-to-consumer wellness brand IM8, co-founded by David Beckham, today announced that IM8 has entered a 10-year, exclusive, worldwide partnership with Authentic Brands Group (“Authentic”) to build Care Bears by IM8, a family health and wellness brand. IM8 will serve as the brand's exclusive operating partner, and Prenetics will record all revenue from Care Bears by IM8 and pay a royalty to Authentic.

GlobeNewsWire·5d ago
Prenetics' IM8 Names Brian J. Rosin as Successor Chief Financial Officer

- Completes planned leadership transition as Prenetics revenue is almost entirely IM8 - Prenetics' finance leadership function now based in the United States - The Company will report third quarter 2026 results on November 18, 2026, and host a live-streamed earnings event on Stocktwits the same day at 8:30 a.m. Eastern Time, during which management will discuss the results and hold a Q&A session.

PRNewsWire·Oct 14, 2026
CAMTEK PRE-ANNOUNCES RECORD Q3 REVENUES ABOVE GUIDANCE; PROVIDES RECORD Q4 GUIDANCE AND INITIAL REVENUE OUTLOOK FOR 2027

Q3 revenues expected to be $160-161 million; 2026 revenue guidance at approximately $595 million and 2027 initial revenue outlook at over $800 million MIGDAL HAEMEK, Israel, Oct. 14, 2026 /PRNewswire/ -- Camtek Ltd (NASDAQ: CAMT) (TASE: CAMT), in advance of its upcoming investor and analyst breakfast, announced today that its revenue for the third quarter ended September 30, 2026, is expected to be slightly above the previously issued guidance range and also introduced its revenue guidance for full year 2026 and an initial outlook for year 2027. Camtek expects revenue for the third quarter of 2026 to be $160-161 million, representing a year-over-year increase of 27%.

Filtered for Prenetics Global LimitedMore Headlines
04

Compare before deciding

Benchmark PRE against direct peers instead of judging its metrics in isolation.

Peers Comparison

Key metrics vs top competitors for Prenetics Global Limited (PRE)

Full Screener →
CompanyPriceMarket CapP/E RatioRev Growth (1Y)Net MarginROEDiv Yield
PRE logoPREPrenetics Global LimitedCurrent
$15.94$270.99M-4.07201.72%-47.43%-49.2%—
NTRA logoNTRANatera, Inc.
$310.67$44.49B-271.7335.9%-5.66%-9.18%—
CSTL logoCSTLCastle Biosciences, Inc.
$32.52$986.33M-43.293.66%-6.1%-4.89%—
QDEL logoQDELQuidelOrtho Corporation
$10.70$729.64M-1.99-1.89%-14.24%-20.13%—
AHCO logoAHCOAdaptHealth Corp.
$7.33$997.28M-2.46-0.49%-12.9%-28.74%—
HIMS logoHIMSHims & Hers Health, Inc.
$26.00$5.8B-42.4259%-5.51%-30.03%—

Compare PRE vs Peers

Prenetics Global Limited (PRE) vs competitors — business, growth, and fundamentals comparison against the closest industry rivals.

Closest Rival

vs NTRA

Most directly comparable listed peer for PRE.

Scale Benchmark

vs TMO

Larger-name benchmark to compare PRE against a more recognizable public peer.

Peer Set

Compare Top 5

vs NTRA, CSTL, QDEL, AHCO

Get notified when PRE posts new earnings or crosses analyst targets

Free. No account needed. Unsubscribe any time.

Free. Unsubscribe any time.

PRE Frequently Asked Questions

Prenetics Global Limited (PRE) stock FAQ — growth, dividends, profitability & financials explained

Growth & Financials
What is Prenetics Global Limited's revenue?

Prenetics Global Limited (PRE) reported $142.6M in revenue over the trailing twelve months. Revenue was $92.4M in fiscal year 2025. That is 901% more than the $9.2M of fiscal year 2019.

How fast is Prenetics Global Limited growing?

Prenetics Global Limited (PRE) grew revenue by 167.7% over the trailing twelve months, compared with the twelve months before.

Is PRE profitable?

No. Prenetics Global Limited (PRE) reported a net loss of $67.6M over the trailing twelve months.

Dividend & Returns
What is PRE's return on equity?

Prenetics Global Limited (PRE) had a return on equity (ROE) of -49.2% over the trailing twelve months. A negative ROE means the company lost money over the period.

What is Prenetics Global Limited's free cash flow?

Prenetics Global Limited (PRE) had negative free cash flow of $34.1M over the trailing twelve months.

What if you invested $1,000 in PRE back in 2019?

Total return calculator · dividends reinvested · 7+ years of data

See returns →